Biperiden to prevent seizures after traumatic brain injury
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests whether biperiden can lower the chance of developing epilepsy after an acute traumatic brain injury (with bleeding or bruising seen on CT). If you qualify, you would get the medicine or a placebo soon after the injury, and researchers will compare outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to give informed consent (or have a legal representative).
- Age 18 to 75 years.
- You were admitted with a moderate to severe traumatic brain injury and your brain CT shows bleeding in the brain and/or bruising (contusion).
- Your first study dose/placebo must be given within 18 hours after the brain injury.
- You should not have a history of epilepsy, prior seizures, or taking seizure medicines.
- You cannot be pregnant and you cannot be taking biperiden already; you also must not be in another clinical trial at the time of randomization.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving medication right after a serious head injury can prevent early seizures. It may help people with certain types of brain injuries seen on CT scans.
This trial tests two medicines, levetiracetam and lacosamide, to see which works better at preventing seizures in people who have had a traumatic brain injury. The goal is to find the safest and most effective way to protect your brain after injury.
This study tests whether giving anti-seizure medication right after a serious head injury can prevent seizures from developing. Researchers want to see if early treatment can protect your brain and reduce complications.
This study tests drug treatment strategies to reduce seizures after a traumatic brain injury (TBI). It may help prevent new seizure problems or improve seizure control after certain types of brain injury events.
This trial tests whether giving a drug called levetiracetam (which is normally used to prevent seizures) soon after a type of stroke called a brain bleed (intracerebral haemorrhage) can improve recovery. It is a randomised, double-blind trial, meaning half the participants get the drug and half get a placebo (a dummy pill), and neither you nor the doctors know which one you are taking.
This trial tests whether taking an anti–blood clot medicine (dalteparin) and using leg compression can reduce dangerous blood clots after a severe traumatic brain injury. It may help lower the chance of clots forming when people are immobile and at higher risk.
Hear when a new Brain Injury Traumatic Moderate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.